Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Baseline details and univariate associations with GDF-15 levels (n = 146) [11] Factor | Baseline level | Correlation versus log10GDF-15 | p for correlation | | | Mean log10GDF-15Present versus absent | p for comparison: 25OHD (nmol/L) (SD) | 44 (15) | −0.11 | 0.17

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted analyses using samples and data collected prospectively as part of the vitamin D in isolated systolic hypertension (VitDISH) randomised controlled trial, which tested the effect of vitamin D supplementation on blood pressure in patients aged 70 and over with isolated systolic hypertension [].

Source: Methods.

We conducted analyses using samples and data collected prospectively as part of the vitamin D in isolated systolic hypertension (VitDISH) randomised controlled trial, which tested the effect of vitamin D supplementation on blood pressure in patients aged 70 and over with isolated systolic hypertension [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

Randomised controlled trial · Aging Clinical and Experimental Research · 2016

Original publication title

Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

Maryam Barma; Faisel Khan; Rosemary J. G. Price; Peter T. Donnan; C. Martina Messow; Ian Ford; Alex McConnachie; Allan D. Struthers; Marion E. T. McMurdo; Miles D. Witham

© The Author(s) 2016

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Baseline GDF-15 predicts declining physical, but not vascular, function in our population.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To correlate baseline GDF-15 levels with physical and vascular health data in this population.

Source: Aims

Abstract: What methods does the paper describe?

Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.

Source: Methods

Abstract: Results

A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models.

No significant correlations were seen with changes in vascular function over 12 months.

Source: Results

Abstract: Conclusion

Baseline GDF-15 predicts declining physical, but not vascular, function in our population.

Source: Conclusion
Authors’ abstract

Background

Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension.

Aims

To correlate baseline GDF-15 levels with physical and vascular health data in this population.

Methods

Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.

Results

A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models.

No significant correlations were seen with changes in vascular function over 12 months.

Conclusion

Baseline GDF-15 predicts declining physical, but not vascular, function in our population.

Publication and source details

Original title: Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

Maryam Barma; Faisel Khan; Rosemary J. G. Price; Peter T. Donnan; C. Martina Messow; Ian Ford; Alex McConnachie; Allan D. Struthers; Marion E. T. McMurdo; Miles D. Witham

Aging Clinical and Experimental Research · 2016

© The Author(s) 2016https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.http://dx.doi.org/10.13039/501100000589Chief Scientist OfficeCZH/4/1100

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:57:13.323065+00:00

DOI: 10.1007/s40520-016-0636-0 · PMC5589783